about
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial.CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results.Three-day topotecan schedule in heavily pretreated recurrent ovarian cancer patients.Surgical management of advanced and recurrent cervical cancer.Primary malignant melanoma of the uterine cervix: case report and review of the literature.Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.Urinary diversion in gynecologic oncology.Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivoAssociation of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Modulation of surgery in early invasive cervical cancer.Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review.Guidelines of how to manage vesicovaginal fistula.Bowel preparation for gynecological surgery.HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trialDual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo.Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvisAortic lymphadenectomy in cervical cancer: anatomy, classification and technique.Update on lymphadenectomy in early and advanced ovarian cancer.Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact.A critical review on HE4 performance in endometrial cancer: where are we now?Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature.p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review.Ten years of HPV vaccines: State of art and controversies.Which are the most common thrombophilic genetic nucleotide polymorphisms in infertile women undergoing an IVF cycle?Continent ileocolonic urinary diversion (Rome pouch) for gynecologic malignancies: technique and feasibility.The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study.A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery.Should sacrospinous ligament fixation for the management of pelvic support defects be part of a residency program procedure? The University of Miami experience.Chemotherapy as Adjuvant Treatment for Intermediate-High Risk Early-Stage Endometrial Cancer: A Pilot Study.Radical hysterectomy for stage IB adenocarcinoma of the cervix: the University of Miami experience.Ovarian remnant syndrome: experience at Jackson Memorial Hospital, University of Miami, 1985 through 1993.Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection.Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.Taxol as a radiation sensitizer: a flow cytometric study.Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.Diagnostic open laparoscopy in the management of advanced ovarian cancer.
P50
Q30352997-598E1C7B-34F2-4942-8CCB-A04C6D8B5759Q31111545-F9CBFF51-668F-4204-A2D0-26722EB85884Q33384306-7F6C5AF6-58B8-40D3-A49C-40B7160ACF60Q33606215-424AD556-9D11-4BB1-8FB6-2EF24F3D63F9Q33741132-124AF989-6119-4234-98AB-70E040851E3CQ34106088-B63EF8C0-0A40-4854-9404-ED16752DF70DQ34364699-CCE53C47-84EE-4129-8166-241EAB6028C1Q34729807-A2E2688C-4615-411C-972A-D357971B1FAAQ35004607-FE2F8B6C-F59D-4412-84A6-EB8C08D8F6D1Q35328194-6BAD2120-DD87-42EB-9525-A65F66FCD65FQ35615266-37967679-FBBC-4304-A8EF-D7AF4CAA2DC1Q35615284-4FC96611-E5FE-44BB-8E7E-E4B007207002Q35615288-0CE9EF07-486F-4592-A34F-8C3AA90A8B40Q35615292-63ACFEB0-F155-4590-AEBE-18C4ED0E0305Q36004109-B03A82DC-E135-4883-8D08-E181CC150421Q36184223-141D29AD-68FA-48FA-B15F-DAD133E4B449Q36258125-1A7A128E-AB91-438D-B604-6D6E8F574B19Q36611666-5E65DEAC-5753-4ACC-BCFA-092E10C01F91Q36922658-A7DEB465-5900-4B45-843E-C363AEA4782DQ37057639-177E81BF-6937-49AB-A513-2C9C2A9EF249Q37373716-E85FCC6D-E8C4-4995-A0B1-1BF584D40679Q38143730-653D9E7A-E414-46FD-AAD3-47B09255EBF8Q38183890-D689129D-A1D6-4D93-BE83-6C4661909909Q38344551-758499EC-CFC6-49AD-9439-1EC32250D562Q38426654-905E13E4-3469-4C86-9F30-FB4394D50F99Q38804950-791C816D-37ED-4069-8B0A-A698357338CCQ39737187-912F30A6-6B83-457B-A55D-20BA82F973E9Q40184963-13AB879F-0584-4BB2-A11B-312C411C7D70Q40365792-93880836-14AF-44FA-BD14-1F068B32F206Q40475646-B4B5FB95-497B-437B-918A-F1C5E66F84E3Q40640998-E365BD9C-B5A6-40E4-9B2A-49ED17A4CA30Q40725029-DA0652BC-B247-4050-8117-C5AAE6F9EC28Q40891891-1620350E-7B9F-4AE8-B972-5E16BCFB3682Q40982886-932CB595-6306-4E99-8FC5-11AEBA0BC9A9Q41004118-6248C542-9DC7-4E91-983F-73870242B4DBQ41161911-2162F312-C118-49FD-BBA1-CBA48D82978FQ41174367-5D259DE7-6447-46E9-B21F-AA95959323EEQ41545955-22425BBC-6C8B-4BC0-A4A1-8DFEA6FB9030Q41608306-8319CC80-C319-4C3F-8821-C0D06E96C034Q42674626-278F0A5E-6526-4848-8336-C9BE6CA78D8C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Roberto Angioli
@ast
Roberto Angioli
@en
Roberto Angioli
@es
Roberto Angioli
@nl
Roberto Angioli
@sl
type
label
Roberto Angioli
@ast
Roberto Angioli
@en
Roberto Angioli
@es
Roberto Angioli
@nl
Roberto Angioli
@sl
prefLabel
Roberto Angioli
@ast
Roberto Angioli
@en
Roberto Angioli
@es
Roberto Angioli
@nl
Roberto Angioli
@sl
P1053
K-4172-2016
P106
P1153
35512061600
P21
P31
P3829
P496
0000-0002-8528-4318